PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Go Deep

Merck & Co., Inc.

Merck & Co., Inc. Score & Ratio Trend

DateScoreP/EP/BD/EPrice
Oct 2026 15,119 114.5 8.49 1.28 13,879.77
Oct 2026 15,119 114.5 8.49 1.28 13,878.34
Oct 2026 15,119 114.5 8.49 1.28 13,878.34
Oct 2026 15,415 110.7 8.21 1.28 13,420.54
Oct 2026 15,516 112.7 8.35 1.28 13,685.58
Oct 2026 15,516 112.7 8.35 1.28 13,685.58
Oct 2026 15,463 113.3 8.40 1.28 13,784.35
Oct 2026 15,488 113.0 8.38 1.28 13,744.77
Oct 2026 15,039 115.6 8.57 1.28 14,087.73
Oct 2026 15,047 115.4 8.56 1.28 13,925.46
Oct 2026 15,905 112.7 8.35 1.28 13,521.28
Oct 2026 15,570 117.0 8.67 1.28 13,992.41
Oct 2026 15,705 115.2 8.54 1.28 13,787.39
Oct 2026 15,658 115.8 8.59 1.28 13,823.65
Oct 2026 15,802 114.0 8.45 1.28 13,618.48
Oct 2026 15,512 117.7 8.72 1.28 14,061.27
Oct 2026 15,414 119.0 8.82 1.28 14,175.98
Oct 2026 15,578 116.9 8.66 1.28 13,898.10

Merck & Co., Inc. Quarterly Results

Line Item Jun 2026Mar 2026Dec 2025Sep 2025
Revenue 16,607,000,000.0 16,286,000,000.0 16,400,000,000.0 17,276,000,000.0
Net Profit -1,335,000,000.0 -4,240,000,000.0 2,963,000,000.0 5,785,000,000.0
EPS -0.5 -1.7 1.2 2.3

Merck & Co., Inc. Revenue & Profit: Last 5 Years

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue 65,011,000,000.0 64,168,000,000.0 60,115,000,000.0 59,283,000,000.0 —
Net Profit 18,254,000,000.0 17,117,000,000.0 365,000,000.0 14,519,000,000.0 —
EPS 7.4 6.8 0.1 5.7 —

Merck & Co., Inc. Balance Sheet

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Total Assets 136,866,000,000.0 117,106,000,000.0 106,675,000,000.0 109,160,000,000.0 —
Total Liabilities 84,204,000,000.0 70,734,000,000.0 69,040,000,000.0 63,102,000,000.0 —
Total Equity 52,606,000,000.0 46,313,000,000.0 37,581,000,000.0 45,991,000,000.0 —

Owes vs Owns

Merck & Co., Inc. owed $0.68 for every $1 it owned in Jun 2026, up from $0.58 in Dec 2022.

PeriodJun 2026Dec 2025Dec 2024Dec 2023Dec 2022
Owes vs Owns 0.68× 0.62× 0.60× 0.65× 0.58×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

Merck & Co., Inc. Assets & Liabilities Breakdown (USD millions)

What it owns — Dec 2025

Cash & short-term investments 10.6%Receivables 8.6%Inventory 4.9%Fixed assets (tangible) 18.5%Intangible assets 35.3%Long-term investments 0.7%Other assets 21.4%

How it's funded — Dec 2025

Short-term debt 1.9%Long-term debt 34.2%Payables 3.2%Other liabilities 22.3%Shareholders' equity 38.5%
Line Item Dec 2025Dec 2024Dec 2023Dec 2022
Assets
Cash & short-term investments14,565.013,689.07,093.013,192.0
Receivables11,775.010,278.010,349.09,450.0
Inventory6,658.06,109.06,358.05,911.0
Fixed assets (tangible)25,316.023,779.023,051.021,422.0
Intangible assets48,260.038,038.039,208.041,473.0
Long-term investments956.0463.0252.01,015.0
Other assets29,336.024,750.020,364.016,697.0
Liabilities & equity
Short-term debt2,589.02,649.01,372.01,946.0
Long-term debt46,750.034,462.033,683.028,745.0
Payables4,404.04,079.03,922.04,264.0
Other liabilities30,461.029,544.030,063.028,147.0
Shareholders' equity52,662.046,372.037,635.046,058.0
Net tangible assets4,346.08,275.0-1,627.04,518.0

Merck & Co., Inc. Cash Flow

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Operating Activities 16,472,000,000.0 21,468,000,000.0 13,006,000,000.0 19,095,000,000.0 —
Investing Activities -13,741,000,000.0 -7,734,000,000.0 -14,083,000,000.0 -4,960,000,000.0 —
Financing Activities -1,922,000,000.0 -7,032,000,000.0 -4,810,000,000.0 -9,119,000,000.0 —

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.